BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 318094)

  • 21. Levels of HCG in subjects using the Progestasert(TM) intrauterine progesterone systems.
    Custo GM; Carenza L; Pala A
    Contraception; 1980 Mar; 21(3):311-7. PubMed ID: 6771092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fertility regulation technology: status and prospects.
    Segal SJ; Nordberg OS
    Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of plasma human chorionic gonadotropin (hCG) and beta-hCG activities in the late luteal phase: evidence of the occurrence of spontaneous menstrual abortions in infertile women.
    Chartier M; Roger M; Barrat J; Michelon B
    Fertil Steril; 1979 Feb; 31(2):134-7. PubMed ID: 761674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
    Videla-Rivero L; Etchepareborda JJ; Kesseru E
    Contraception; 1987 Aug; 36(2):217-26. PubMed ID: 3123135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
    Balogh A; Ditrói F; Lampé LG
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
    Prema K
    Contracept Deliv Syst; 1982 Jan; 3(1):39-46. PubMed ID: 12264126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal pH effects caused by OCs and various copper and inert IUDs.
    Kandil O; Hassanein MK; El-tagi A; El-shirbini MT
    Contracept Deliv Syst; 1983 Jul; 4(3):187-93. PubMed ID: 12265361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The acceptability of current contraceptive methods to adolescents].
    Sotnikova EI; Dubnitskaia LV; Perminova SG
    Akush Ginekol (Mosk); 1993; (3):26-30. PubMed ID: 8048682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancy specific beta 1-glycoprotein and human chorionic gonadotrophin levels n amniotic fluid and maternal serum in the first half of pregnancy.
    Heikinheimo M; Seppälä M; Brock DJ
    Oncodev Biol Med; 1980 Aug; 1(1):71-6. PubMed ID: 6974343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state.
    de Kretser DM; Burger HG; Dumpys R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy-specific beta-1 glycoprotein in ectopic pregnancy.
    Seppälä M; Venesmaa P; Rutanen EM
    Am J Obstet Gynecol; 1980 Jan; 136(2):189-93. PubMed ID: 6965436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
    Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
    Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of choriocarcinoma by the hCG beta-to-hCG proportion in patients with delayed diagnosis caused by contraceptive use.
    Vartiainen J; Alfthan H; Lehtovirta P; Stenman UH
    Contraception; 1998 Apr; 57(4):257-60. PubMed ID: 9649918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraception.
    Christensen JT; Boldsen J; Westergaard JG
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):784-9. PubMed ID: 9348259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of prior pregnancy and combined oral contraceptives on baseline menstrual blood loss and bleeding response to intrauterine devices.
    Andrade AT; de Souza JP; Rowe PJ; Shaw ST
    Contraception; 1979 Jul; 20(1):19-26. PubMed ID: 477314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of human chorionic gonadotropin in blood of regularly bleeding women using copper intrauterine contraceptive devices.
    Landesman R; Coutinho EM; Saxena BB
    Fertil Steril; 1976 Sep; 27(9):1062-6. PubMed ID: 964399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of elevated circulating levels of LH during the pre-menstrual period in some copper IUD users and the possibility of their confusion with hCG.
    Dattatreyamurty B; Joshi J; Mehta S; Virkar KD; Sheth AR
    Contraception; 1979 Mar; 19(3):213-21. PubMed ID: 455978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.